Making best practice, everyday practice

Login Register

GLP-1 Summit – Key learnings about the added benefits of GLP-1 in diabetes

Increased cardiovascular risk in T2DM demands early intervention; long-acting GLP-1 receptor agonists not only effectively lower glucose, but have multiple cardioprotective mechanisms of action and are associated with weight loss

Do you like this? Share with a colleague